Form 4: QuidelOrtho COO Equity Vesting and Tax Withholding

Chief Operations Officer Philip D. McLellan acquired 3,238 shares of QuidelOrtho common stock via RSU vesting, with 1,162 shares withheld for taxes.

Summary

• Philip D. McLellan, Chief Operations Officer of QuidelOrtho Corp, reported the vesting of 3,238 restricted stock units (RSUs) on April 22, 2026.
• The company withheld 1,162 shares to satisfy tax obligations associated with the RSU release.
• Following these transactions, the reporting person holds 21,250 shares of common stock directly.
• An additional 3,238 RSUs remain outstanding, scheduled to vest on April 22, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding executive compensation that does not signal a change in company strategy or financial outlook.

Positives

• The transaction reflects the fulfillment of long-term incentive compensation for a key executive.
• The executive maintains a significant direct ownership stake of 21,250 shares.

Negatives

• The transaction involved a mandatory tax withholding disposition of 1,162 shares, which is standard practice but reduces the net share gain for the executive.

Risks

• No specific operational or financial risks are disclosed in this ownership filing.

Future Outlook

The filing notes that an additional 3,238 restricted stock units are scheduled to vest on April 22, 2027.

Management Comments

• Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

Industry Context

StockSavvy.ai notes that this is a routine executive compensation disclosure common in the diagnostics and medical device sector, reflecting standard equity-based incentive structures.

Comparison to Industry Standards

• The use of RSU vesting and net-settlement for tax obligations is standard practice for executive compensation among S&P 500 and mid-cap healthcare companies.
• The retention of shares post-tax is consistent with typical executive equity holding requirements.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine equity compensation event.

Next Steps

• Vesting of remaining 3,238 restricted stock units on April 22, 2027.

Key Dates

Keywords

QuidelOrtho, QDEL, Insider Trading, Form 4, Equity Compensation, Executive Ownership